Jul 17, 2008
Story Timeline: 90 days
Word Count: 830 | Companies Featured in This Article: Novartis Former President Bill Clinton's foundation is set to unveil a pricing agreement Thursday that it hopes will make malaria drugs available to millions of poor people. The agreement points to the sophistication needed to harness market forces and get lifesaving medicines to countries where treatable diseases still take a staggering toll. First-line malaria drugs -- known as ACTs, for artemisinin-based combination therapies -- present a tricky problem: the volatile cost of the powerful antimalarial plant extract artemisinin. During the past few years, the price of that key ingredient has fluctuated from as little as $150 a kilogram to as...
[read full story]
Your Web Site
